- Inactivated Vaccine
- Attenuated Live Vaccine
- DNA Vaccine
- Others
Aquaculture Vaccine Market is valued at USD 482.6 million in 2022 and is projected to reach 817.8 million by 2029, at a CAGR of 7.9% from 2023-29. Due to surge in the of prevalence of bacterial and viral infections among aquaculture species, increase in aquaculture production around the globe, and rise in adoption of vaccines by aquaculture farmers. Development and launch of innovative vaccines to treat various infectious diseases in aquaculture species boosting the revenue growth of the market. For instance, In March 2018, Hipra launched Icthiovac VR/PD injectable vaccine for seabass against Vibriosis and Pasteurellosis in Greece. Apart from the aforementioned dynamics, Raise in funding for the research and development of innovative aquaculture vaccines boost the market over forecast years. For instance, In March 2015, The Scottish Aquaculture Innovation Center (SAIC) has announced it is issuing grants worth almost GBP 950,000 to two major salmon farming research projects proposed by leading farmed salmon companies on sea lice and salmon vaccinations.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Increase in the fish mortality due to certain disease outbreaks driving the growth of aquaculture vaccines market. For instance, in October 2017, approximately 125,000 salmon have died due to a disease outbreak at two fish farms on the Isle of Lewis due to bacterium Pasturella Skyensis infection. In addition, surge in population demand for the healthy fish products, demand for animal protein, government support for the aquaculture immunization programs, rise in adoption of aquaculture vaccines in the developed and developing nations are boost the aquaculture vaccines market over the forecast years. Moreover, increase in the international trading of aquaculture species immense boost the global aquaculture vaccines over the forecast period.
The global aquaculture vaccine market is valued at USD 482.6 million in 2022 and is projected to reach 817.8 million by 2029.
The CAGR of the aquaculture vaccines market is 7.6% over the forecast period (2022 - 2028)
Inactivated vaccine type dominates the aquaculture vaccine product segment.
Norway is the big market in the aquaculture vaccines market
Zoetis (Pharmaq), MSD Animal Health, Elanco, and Virbac are the key market players in the aquaculture vaccines market.